Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer

Oncogene - Tập 26 Số 2 - Trang 290-297 - 2007
Frédérique Végran1, Romain Boidot1, Claire Oudin1, Chad DeFrain1, Magali Rebucci1, Sarab Lizard-Nacol1
1Laboratory of Molecular Genetic, Centre Georges François Leclerc, INSERM U-517, Dijon Cedex, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Altieri DC . (2003). Nat Rev Cancer 3: 46–54.

Ambrosini G, Adida C, Altieri DC . (1997). Nat Med 3: 917–921.

Ambrosini G, Adida C, Sirugo G, Altieiri DC . (1998). J Biol Chem 273: 11177–11182.

Badran A, Yoshida A, Ishikawa K, Goi T, Yamagushi A, Ueda T et al. (2004). Biochem Biophys Res Commun 314: 902–907.

Bullok AN, Fersht AR . (2001). Nat Rev Cancer 1: 68–76.

Caldas H, Honsey LE, Altura RA . (2005). Mol Cancer 4: 11–20.

Cawkwell L, Lewis FA, Quirke T . (1994). Br J Cancer 70: 813–818.

Cho Y, Gorina S, Jeffrey PD, Pavletich NP . (1994). Science 265: 336–355.

Dumont P, Leu JI, Della Pietra III AC, George DL, Murphy M . (2003). Nat Genet 33: 357–365.

Estève PO, Chin HG, Pradhan S . (2005). Proc Natl Acad Sci USA 102: 1000–1005.

Franco N, Arnould L, Mege F, Picard SF, Arveux P, Lizard-Nacol S . (2003). Arch Surg 138: 291–295.

Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M . (2002). J Biol Chem 277: 3247–3257.

Livak KJ, Schmittgen TD . (2001). Methods 25: 402–408.

Lohr K, Moritz C, Contente A, Dobbelstein M . (2003). J Biol Chem 278: 32507–32516.

Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD . (1999). Cancer Res 59: 6097–6102.

Maxwell SA, Acosta SA, Davis GE . (1999). Apoptosis 4: 109–114.

Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S et al. (2002). Oncogene 21: 2613–2622.

Moyret-Lalle C, Duriez C, Kerckhove JV, Gilbert C, Wang Q, Puisieux A . (2001). Cancer Res 61: 486–488.

Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ et al. (1999). Genes and Dev 13: 2490–2501.

Nasu S, Yagihashi A, Izawa A, Saito K, Asanuna K, Nakamura M et al. (2002). Anticancer Res 22: 2613–2622.

O'Driscoll L, Linehan R, Kennedy SM, Cronin D, Purcell R, Glynn S et al. (2003). Cancer Lett 201: 225–236.

Punga T, Akusjarvi G . (2003). FEBS Lett 552: 214–218.

Ryan B, O'Donovan N, Browne B, O'Shea C, Crown J, Hill ADK et al. (2005). Br J Cancer 92: 120–124.

Sommer KW, Schamberger CJ, Schmidt GE, Sasgary S, Cerni C . (2003). Oncogene 22: 4266–4280.

Soussi T, Beroud C . (2001). Nat Rev Cancer 1: 233–240.

Tran J, Master Z, Yu J, Rak J, Dumont D, Kerbel R . (2002). Proc Natl Acad Sci USA 99: 4349–4354.

Tsuji N, Furuse K, Asanuma K, Furuya M, Kondoh K, Kamagata C et al. (2004). Breast Cancer Res Treat 87: 23–31.

van Oijen GCT, Slootweg PJ . (2000). Clin Cancer Res 6: 2138–2145.

Végran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S . (2005). Int J Oncol 27: 1151–1157.

Xu M, el-Gewely MR . (2003). Oncol Res 13: 429–436.

Yoon H, Liyanarachci S, Wright FA, Davaluri R, Lockman JC, de la Chapelle A et al. (2002). Proc Natl Acad Sci USA 99: 15632–15637.

Zhou X, Wang XW, Xu L, Hagiwara K, Ngashima M, Wolkowicz R et al. (1999). Cancer Res 59: 843–848.

Zhu N, Gu L, Findley HW, Li F, Zhou M . (2004). Oncogene 23: 7545–7551.